We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
"We are excited to partner with Aptar Pharma to develop a product that can provide patients with a life-saving treatment,” said Bryn Pharma CEO David Dworaczyk. Read More
The new law presumes that “these agreements are anti-competitive and delay the entry of the generic drug into the market place,” notes the state’s Attorney General Xavier Becerra. Read More
Buttigieg’s proposal would take advantage of provisions of the Bayh-Doyle Act to “acquire” companies’ intellectual property when price negotiations fail. Read More